Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
50.20
-1.42 (-2.75%)
At close: Feb 18, 2026, 4:00 PM EST
49.80
-0.40 (-0.80%)
After-hours: Feb 18, 2026, 5:14 PM EST
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 674 employees as of December 31, 2024. The number of employees increased by 22 or 3.37% compared to the previous year.
Employees
674
Change (1Y)
22
Growth (1Y)
3.37%
Revenue / Employee
$1,011,185
Profits / Employee
-$28,364
Market Cap
2.88B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 674 | 22 | 3.37% |
| Dec 31, 2023 | 652 | 40 | 6.54% |
| Dec 31, 2022 | 612 | 37 | 6.43% |
| Jun 30, 2022 | 603 | - | - |
| Dec 31, 2021 | 575 | 12 | 2.13% |
| Dec 31, 2020 | 563 | 99 | 21.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,700 |
| Perrigo Company | 8,379 |
| Amneal Pharmaceuticals | 8,300 |
| Phibro Animal Health | 2,475 |
| HUTCHMED (China) | 1,780 |
| Hims & Hers Health | 1,637 |
| Lantheus Holdings | 808 |
| Prestige Consumer Healthcare | 600 |
SUPN News
- 6 days ago - Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026 - GlobeNewsWire
- 9 days ago - Lunai Bioworks, Inc. Issues Letter to Shareholders - PRNewsWire
- 17 days ago - Supernus: Outlook For 2026 Positive, Upholding Buy Rating - Seeking Alpha
- 4 weeks ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 2 months ago - Supernus Pharmaceuticals, Inc. (SUPN) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference - GlobeNewsWire
- 3 months ago - Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London - GlobeNewsWire